Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9KM3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,835
Award facts
- Contract value 100% obligated
- $12,834.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,834.99 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for the supply of Stelara 45 mg/0.5 ml syringes, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order, awarded on January 9, 2026, represents a non-set-aside procurement executed through open competition. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems including military treatment facilities and veteran healthcare programs.
This delivery order is issued under a larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The parent company, Cencora, Inc., holds a comprehensive IDC with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies globally to support military healthcare operations. The procurement of Stelara, a specialty immunosuppressant medication, demonstrates the company's role in providing critical brand-name pharmaceutical products across multiple therapeutic domains to federal medical supply chains.
Quick answers
Who was awarded contract SPE2DR26F9KM3?
SPE2DR26F9KM3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F9KM3 worth?
The government has obligated $12,835 on SPE2DR26F9KM3.
Is contract SPE2DR26F9KM3 an order under another contract?
Yes. SPE2DR26F9KM3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KM3 competed?
The extent of competition for SPE2DR26F9KM3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award